We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
-11.5%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$97.4M
AUM Growth
-$16M
Cap. Flow
-$1.04M
Cap. Flow %
-1.07%
Top 10 Hldgs %
98.61%
Holding
13
New
1
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$741K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$1.72M
2
SNGX icon
Soligenix
SNGX
+$67.7K

Sector Composition

Rank Sector Weight
1 Healthcare 99.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABEO icon
1
Abeona Therapeutics
ABEO
$345M
$33.9M 34.77%
94,391
– –
CRBP icon
2
Corbus Pharmaceuticals
CRBP
$170M
$23.5M 24.16%
128,566
– –
BHVN
3
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$19.3M 19.83%
749,815
-57,409
-7% -$1.72M
AMPE
4
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$8.82M 9.06%
8,652
– –
KRYS icon
5
Krystal Biotech
KRYS
$9.88B
$3.03M 3.11%
300,000
– –
NTBL
6
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$2.06M 2.12%
25,622
– –
AVXL icon
7
Anavex Life Sciences
AVXL
$222M
$2M 2.05%
724,205
– –
SNGX icon
8
Soligenix
SNGX
$5.5M
$1.64M 1.68%
3,494
-135
-4% -$67.7K
ALDX icon
9
Aldeyra Therapeutics
ALDX
$91.7M
$931K 0.96%
124,096
– –
VNRX icon
10
VolitionRx Ltd
VNRX
$12M
$844K 0.87%
17,577
– –
EIGR
11
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$741K 0.76%
+2,508
New +$741K
EVOK
12
DELISTED
Evoke Pharma
EVOK
$572K 0.59%
1,910
– –
ADXSW
13
DELISTED
Advaxis Inc Warrants
ADXSW
$45K 0.05%
112,500
– –

Similar funds

MGWA
Monument Group Wealth Advisors Concord, Massachusetts $180M AUM 19.81% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Knoll Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Knoll Capital Management held 13 positions worth $97.4M, down 14% from $113M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Knoll Capital Management's Q1 2018 filing shows 1 new and 2 reduced positions. Its largest new stake was Eiger BioPharmaceuticals, Inc.: 2,508 shares worth $741K. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $1.72M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier.

  • Knoll Capital Management's largest Q1 2018 buy was Eiger BioPharmaceuticals, Inc.: 2,508 shares worth $741K.
  • Knoll Capital Management's biggest Q1 2018 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $1.72M.
  • Knoll Capital Management's ten largest holdings make up 99% of its $97.4M portfolio in Q1 2018.
  • Knoll Capital Management opened 1 new position and closed 0 in Q1 2018.
  • Knoll Capital Management's portfolio value fell 14% quarter-over-quarter to $97.4M.

Based on Knoll Capital Management's 13F filing for Q1 2018, filed 15 May 2018.